In a patient taking trazodone 50 mg morning and afternoon, buspirone 5 mg twice daily, mirtazapine 15 mg at bedtime, melatonin 3 mg at bedtime, and lorazepam 0.25 mg twice daily who becomes agitated when lorazepam is omitted, can the other medication doses be kept the same while stopping the afternoon lorazepam dose?

Stopping Afternoon Lorazepam While Maintaining Other Medications

No, you should not simply eliminate the afternoon lorazepam dose while keeping everything else the same, given that the patient becomes agitated when lorazepam is omitted. This patient is demonstrating benzodiazepine dependence, and abrupt discontinuation—even of a single daily dose—risks withdrawal symptoms including the agitation you're already observing.

The Core Problem: Benzodiazepine Dependence

This patient is taking lorazepam 0.25 mg twice daily and becomes agitated when it's omitted. This indicates physiologic dependence has developed. Regular benzodiazepine use leads to tolerance, addiction, and paradoxically can worsen anxiety and agitation 1. The guidelines explicitly warn that benzodiazepines should use "infrequent, low doses of agents with a short half-life" and that regular use is problematic 1.

Why You Cannot Just Stop the Afternoon Dose

The FDA label for lorazepam is clear: "To reduce the risk of withdrawal reactions, use a gradual taper to discontinue lorazepam or reduce the dosage" 2. Withdrawal reactions from benzodiazepines can include:

• Rebound anxiety and agitation (which you're already seeing)
• Seizures
• Delirium
• Autonomic instability

Even reducing from twice daily to once daily constitutes a 50% dose reduction and requires proper tapering.

The Correct Approach: Gradual Benzodiazepine Taper

The evidence-based strategy is to taper lorazepam gradually over weeks to months, not eliminate doses abruptly 3. The recommended approach:

Taper Schedule

• Reduce by 25% of the daily dose every 1-2 weeks (or slower if withdrawal symptoms emerge) 3
• For this patient on 0.5 mg total daily (0.25 mg BID), start by reducing to 0.25 mg morning + 0.125 mg afternoon
• After 1-2 weeks, reduce to 0.25 mg once daily
• Then 0.125 mg once daily
• Then discontinue

If withdrawal symptoms develop at any step, pause the taper or increase back to the previous dose level, then decrease more slowly 2.

Addressing the Underlying Problem

While tapering lorazepam, you need to address why the patient needs anxiolytic therapy:

Non-Pharmacologic Interventions First

Before relying on medications for agitation/anxiety, guidelines emphasize 4:

• Exploring the patient's concerns and anxieties
• Ensuring effective communication and orientation
• Optimizing the environment (adequate lighting, familiar surroundings)
• Educating caregivers on supportive techniques

Current Medication Regimen Analysis

This patient is already on multiple sedating agents:

• Trazodone 50 mg BID: Has anxiolytic and sedating properties 1
• Mirtazapine 15 mg qHS: Sedating antidepressant 1
• Buspirone 5 mg BID: Anxiolytic, though takes 2-4 weeks to become effective 1
• Melatonin 3 mg qHS: For sleep

Optimize Existing Medications

Rather than simply stopping lorazepam, consider:

1. Increase buspirone to therapeutic doses (up to 20 mg TID) 1 - it's currently at subtherapeutic dosing and may provide better anxiety control once optimized

2. Consider increasing trazodone if anxiety/agitation is prominent - can go up to 200-400 mg/day in divided doses 1, though current 100 mg total daily is reasonable

3. Ensure mirtazapine is optimized - 15 mg is a starting dose; therapeutic range extends to 30 mg 1

Critical Drug Interaction Warning

The FDA label for mirtazapine explicitly warns to "avoid taking medicines used to treat anxiety, insomnia, and seizures, called benzodiazepines, during treatment with mirtazapine" 5. This patient is already on a problematic combination. This reinforces the need to taper off lorazepam, but it must be done gradually.

Additionally, combining mirtazapine, trazodone, and buspirone increases serotonin syndrome risk 5, 6. Monitor for agitation, confusion, tachycardia, tremors, and hyperthermia.

Common Pitfalls to Avoid

1. Don't abruptly stop any benzodiazepine dose - even 0.25 mg matters when dependence exists
2. Don't assume agitation means the patient "needs" the lorazepam - it may be withdrawal-induced agitation, creating a vicious cycle
3. Don't add more sedating medications - this patient is already on multiple CNS depressants
4. Don't ignore the polypharmacy - five psychotropic medications suggests inadequate optimization of individual agents

Monitoring During Taper

Watch for:

• Worsening anxiety or agitation (may need slower taper)
• Sleep disturbance
• Tremor, sweating, tachycardia (autonomic withdrawal signs)
• Confusion or delirium
• Falls risk (elderly patients on multiple sedating medications) 7

The goal is complete benzodiazepine discontinuation over 4-12 weeks while optimizing the safer alternatives already prescribed 3.